{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:15:08Z","timestamp":1775916908702,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":550,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.exphem.2023.05.003","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T11:30:47Z","timestamp":1684409447000},"page":"28-33.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3718-585X","authenticated-orcid":false,"given":"Chinmayee","family":"Goda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Kolovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Rudich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malith","family":"Karunasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0301-4582","authenticated-orcid":false,"given":"Girish","family":"Rajgolikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotus","family":"Neidemire-Colley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satishkumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuvrat","family":"Sircar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4963-3629","authenticated-orcid":false,"given":"Parvathi","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramiro","family":"Garzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1151-5427","authenticated-orcid":false,"given":"Lalit","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne M.","family":"Dorrance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2023.05.003_bib0001","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.18632\/oncotarget.7132","article-title":"Clonal relationships in recurrent B-cell lymphomas","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2023.05.003_bib0002","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood-2011-10-322446","article-title":"EGFL7: a unique angiogenic signaling factor in vascular development and disease","volume":"119","author":"Nichol","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2023.05.003_bib0003","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/cancers13051014","article-title":"The multifaceted roles of EGFL7 in cancer and drug resistance","volume":"13","author":"Heissig","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2023.05.003_bib0004","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1172\/JCI67892","article-title":"Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy","volume":"123","author":"Johnson","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2023.05.003_bib0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1634\/theoncologist.2017-0690","article-title":"Randomized Phase II trial of Parsatuzumab (anti-EGFL7) or placebo in combination with carboplatin, paclitaxel, and bevacizumab for first-line nonsquamous non-small cell lung cancer","volume":"23","author":"von Pawel","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.exphem.2023.05.003_bib0006","doi-asserted-by":"crossref","first-page":"E4641","DOI":"10.1073\/pnas.1703142114","article-title":"Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia","volume":"114","author":"Papaioannou","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2023.05.003_bib0007","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1158\/1078-0432.CCR-19-2479","article-title":"EGFL7 antagonizes NOTCH signaling and represents a novel therapeutic target in acute myeloid leukemia","volume":"26","author":"Bill","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2023.05.003_bib0008","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/bloodadvances.2019001002","article-title":"The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models","volume":"4","author":"Salama","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2023.05.003_bib0009","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1200\/JCO.2016.70.7901","article-title":"New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2023.05.003_bib0010","first-page":"2209","article-title":"PDGFD induces ibrutinib resistance of diffuse large Bcell lymphoma through activat1ion of EGFR","volume":"21","author":"Jin","year":"2020","journal-title":"Mol Med Rep"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X23002266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X23002266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:38:38Z","timestamp":1759567118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X23002266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":10,"alternative-id":["S0301472X23002266"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2023.05.003","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2023.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of ISEH \u2013 Society for Hematology and Stem Cells.","name":"copyright","label":"Copyright"}]}}